AEON: AEON Biopharma Inc. Company Short-Term Debt

Symbol and logo of brand AEON Biopharma (AEON)

AEON Biopharma (AEON) operations are subject to threats of failed new drug trials and patent disputes, while the company relies on external contractors for drug manufacturing and research. The market dynamics reflected in the price action captured the 0.00 metric. Expected results from the final trials of migraine treatments will serve as a growth trigger, as investors have already priced in the colossal R&D expenditures.

AEON (aeonbiopharma.com) Company Short-Term Debts history from 02/21/2024 to 10/30/2026

Financial and market metric breakdowns for AEON Biopharma Inc. (AEON)

- current quotes and average value forecast:
Price Chart AEON Bio|AEON - Fair Value Consensus
- market capitalization information:
Market Value AEON Biopharma, Inc.|AEON - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share AEON Biopharma|AEON - Book Capitalization|Market Cap to Net Assets Ratio aeonbiopharma.com|AEON - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity AEON Biopharma|AEON - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital AEON Bio|AEON - Company Cumulative Debt|Debt to Book Value AEON Biopharma, Inc.|AEON - Company Long-Term Debts|Company Short-Term Debt AEON Biopharma|Quick Liquidity aeonbiopharma.com
- net income and valuation multiples indicators:
AEON - Company Net Income
Basic company analysis:aeonbiopharma.com - AEON
Mass-produced product of AEON Biopharma Inc.

This indicator captures the total volume of liabilities with a maturity of up to one year, allowing for an assessment of current liquidity and the issuer's default risk. By analyzing the short-term debt balance, an investor determines the ability of AEON Biopharma (AEON) to fund costly R&D projects for the development of migraine therapy drugs without compromising operational stability or scientific activities.

Competitors of AEON Biopharma (AEON)

JAZZ - Company Short-Term Debt|Company Short-Term Loans and Borrowings CYTK (Cytokinetics Inc.)|PTC Therapeutics Corp (PTCT) - Company Short-Term Debt|Company Current Liabilities Scholar Rock Inc.|CNTA (Centessa Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts dyne-tx.com|Company Current Liabilities EWTX (Edgewise Therapeutics, Inc.)|RAPP (Rapport Therapeutics Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Alumis Corp ALMS|ZVRA: Company Short-Term Indebtedness|Contineum Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt larimartx.com|CAPR (capricor.com) - Company Current Liabilities|Entrada Therapeutics Inc. (TRDA) - Company Short-Term Debts|Company Short-Term Debt Channel|MNOV: Company Short-Term Loans and Borrowings|Company Short-Term Debt Serina Therapeutics, Inc. (SER)|BTAI - Short-Term Debt|Company Short-Term Debt ProMIS Neurosciences, Inc. PMN|Apimeds Pharmaceuticals, Inc. - Company Short-Term Debt|NLSP - Company Short-Term Debt|Short-Term Debt Bionomics Limited|HUGE: Company Short-Term Debts|Short-Term Indebtedness reatapharma.com RETA